GlassScriptPhysician profile
Richard David Abrash
NPI 1225087703
$8,922.13
in general payments reported to CMS, 2019-2025
39 companies · $1,573 in 2025
The $1,573 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,744 · 2020: $793 · 2021: $1,639 · 2022: $893 · 2023: $613 · 2024: $1,667 · 2025: $1,573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,853.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,034.53 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $1,631.71 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Lilly USA, LLC | $664.77 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $568.82 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Kowa Pharmaceuticals America, INC. | $551.08 | 2019-2022 | |
| Amarin Pharma, INC. | $543.10 | 2019-2022 | |
| Esperion Therapeutics, INC. | $437.75 | 2021-2024 | Nexletol |
| Eisai INC. | $234.84 | 2020-2025 | |
| Renalytix Ai, INC. | $206.35 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Abbvie INC. | $186.68 | 2021-2023 | Qulipta |
| Takeda Pharmaceuticals U.S.A., INC. | $172.35 | 2019 | |
| Medtronic, INC. | $162.56 | 2025 | Osteocool Rf Ablation System |
| Amgen INC. | $138.06 | 2024 | Repatha |
| Xeris Pharmaceuticals, INC. | $125.00 | 2025 | Gvoke Hypopen |
| Insightec,INC | $105.93 | 2025 | Exablate |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Abrash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.